Cancer vaccines for hepatocellular carcinoma: future directions.

about

A sensitive three monoclonal antibodies based automatic latex particle-enhanced turbidimetric immunoassay for Golgi protein 73 detection.Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations.

P2860

Q37560881-6B9E22F0-C024-423D-8EA9-BFBC2934FD9A Q54963955-FDA71699-5851-4B1F-8A35-18E9CFDA089C

P2860

Cancer vaccines for hepatocellular carcinoma: future directions.

Item

http://www.wikidata.org/entity/Q44211246

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Cancer vaccines for hepatocellular carcinoma: future directions.

@en

Cancer vaccines for hepatocellular carcinoma: future directions.

@nl

type

Item

label

Cancer vaccines for hepatocellular carcinoma: future directions.

@en

Cancer vaccines for hepatocellular carcinoma: future directions.

@nl

prefLabel

Cancer vaccines for hepatocellular carcinoma: future directions.

@en

Cancer vaccines for hepatocellular carcinoma: future directions.

@nl

P1476

Cancer vaccines for hepatocellular carcinoma: future directions.

@en

P2093

Franco M Buonaguro

http://www.w3.org/2001/XMLSchema#string

Luigi Buonaguro

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer genome landscapes

Cryoablation induces greater inflammatory and coagulative responses than radiofrequency ablation or laser induced thermotherapy in a rat liver model.

A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma

Neoantigens in cancer immunotherapy.

The Tübingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy.

The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors

Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC.

Management of hepatocellular carcinoma: beyond sorafenib.

Medical therapies for hepatocellular carcinoma: a critical view of the evidence.

Challenges in cancer vaccine development for hepatocellular carcinoma.

P304

391-393

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.2217/IMT-2015-0018

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26973120

http://www.w3.org/2001/XMLSchema#string

Cancer vaccines for hepatocellular carcinoma: future directions.

about

P2860

P2860

Cancer vaccines for hepatocellular carcinoma: future directions.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698